Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NOXAFIL
- Neuro-pharmacological Study of Posaconazole for High-grade Gliomas: A Phase 0 Clinical Trial
- DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
- PTX3-targeted Antifungal Prophylaxis
- Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With the Tablets Formulation and Evaluation of the Po
- HDM201 Added to CT in R/R or Newly Diagnosed AML
- Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients
- Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
- Dosing Obese With Noxafil® Under a Trial (DONUT)
- Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
- Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections
- Effect of Inflammation on Pharmacokinetics of Posaconazole
- Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
- Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
- Gastrointestinal Behavior of Posaconazol in Healthy Volunteers
- Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)
- Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
- Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
- Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)
- Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)
- Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
- Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
- Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)
- A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)
Clinical trials list
click for details